Key result
ABIOS protocol details a cross-sectional approach to characterize molecular, physiological, and digital ageing biomarkers.
Why the study?
Ageing drives chronic diseases, but Asian populations have traditionally been underrepresented in studies understanding age-related diseases.
Cross-Sectional (n=420)
No
The ABIOS study protocol outlines a comprehensive cross-sectional approach to characterizing molecular, physiological, and digital biomarkers of aging in a multi-ethnic Southeast Asian population.
Hypothesis-generating for ageing biomarkers in multi-ethnic Southeast Asians; leaves open prospective validation before clinical adoption.
Ageing is the primary driver of age-associated chronic diseases and conditions. Asian populations have traditionally been underrepresented in studies understanding age-related diseases. Thus, the Ageing BIOmarker Study in Singaporeans (ABIOS) aims to characterise biomarkers of ageing in Singaporeans, exploring associations between molecular, physiological, and digital biomarkers of ageing. This is a single-centre, cross-sectional study that recruits healthy community-dwelling adults (≥ 21 years) from three different ethnic groups (Chinese, Malay, and Indian). Molecular biomarkers of ageing include multi-omics approaches, such as DNA methylation analysis and metabolic and inflammatory proteomic profiling in blood, saliva, and stool. Physiological biomarkers of ageing include bone density, body composition, skin autofluorescence, arterial stiffness, physical performance (e.g., muscle strength and flexibility), cognition, and nutritional status. Digital biomarkers of ageing include three-dimensional facial morphology and objectively measured physical activity. Additional measures, such as habitual physical activity, dietary patterns, and medical history, are also examined. The associations between the molecular, physiological, and digital phenotypes will be explored. This study is expected to generate a comprehensive profile of molecular, physiological, and digital biomarkers of ageing in Chinese, Malay, and Indian populations in Singapore. By integrating diverse age-related biomarkers, clinical indicators, and lifestyle factors, ABIOS will offer unique insights into the ageing process specific to Southeast Asian populations. These findings can help identify markers of biological ageing, uncover ethnic-specific patterns, and reveal modifiable lifestyle factors for healthier ageing. The results could inform evidence-based health policies, personalized interventions, and future cross-ethnic comparative studies to enhance understanding of ageing biology across diverse populations.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2025) conducted a cross-sectional in Healthy aging (n=420). The Ageing BIOmarker Study in Singaporeans (ABIOS) protocol outlines a cross-sectional approach to characterize molecular, physiological, and digital biomarkers of ageing in up to 420 healthy adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: